MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617031903 A) filed by Alumis Inc. on March 17, 2026, for Immediate-Release Formulations Of A Tyk2 Inhibitor.
Inventors include Alonzo, David; Han, Chien-Hsuan; Schlesinger, Erica; and Wald, Randy J..
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Described herein are immediate-release, oral tablet compositions for treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.
Disclaimer: Curated by HT Syndication.
